Doppler and Advanced Techniques in Urologic Ultrasound Prerequisite (2017)

The advanced urologic ultrasound course is designed for participants who have a basic understanding of the physics of ultrasound and some experience with clinical scanning.  This course teaches the physics of Doppler ultrasound and how to use physical principles to improve image quality and understand ultrasound artifacts.  The course is important for those urologists seeking to improve their ultrasound expertise in the operating room and in the office.  

The Doppler and advanced techniques presented in this video will instruct participants in the physics, machine settings,  and techniques for performing  power, color and spectral Doppler ultrasound in the practice of urology. The use of ALARA in the performance of Doppler ultrasound will be discussed. The advanced features of ultrasound  will be demonstrated with an eye toward practical utilization in the office and operating room settings. The clinical indications for the performance of Doppler ultrasound will be presented. 

This activity satisfies the AIUM requirement – “The physician should complete 10 hours of AMA PRA Category 1 Credits™ specific to genitourinary ultrasound every 3 years.”  

Target Audience

  • Urologists
  • Urology Residents

Learning Objectives

After completing this activity, the participants should be able to:

  1. Identify the clinical indications for the performance color, power and/or spectral Doppler ultrasound.
  2. Describe the steps for calculating resistive indices and interpreting the results.
  3. State the principles associated with ALARA for the use of ultrasound.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Course opens: 
09/01/2017
Course expires: 
09/01/2020
Rating: 
0

Faculty
The content of this enduring material was developed by Pat Fox Fulgham, MD.

Faculty Disclosures
Pat Fox Fulgham, MD: Urology Clinics of North Texas: Investment Interest
 

Planners
Planning Committee Members’ Disclosures

Urologic Diagnostic & Therapeutic Imaging Committee (UDTIC)

Ronney Abaza, MD
Disclosures: Intuitive Surgical Inc: Other; Surgiquest Inc.: Scientific Study or Trial; Ohio Urological Society: Leadership Position

Dean G. Assimos, MD
Disclosures: Oxalosis and Hyperoxaluria Foundation (OHF): Consultant or Advisor; Medical Review in Urology: Health Publishing; Urology Times: Health Publishing; National Institute of Health (NIH): IScientific Study or Trial

Kimberly Chancy
Disclosures: Nothing to disclose

Patrick N. Ciccone, MD
Disclosures: Nothing to disclose

Pat Fox Fulgham, MD
Disclosures: Urology Clinics of North Texas: Investment Interest

Frederick A. Gulmi, MD
Disclosures: Brooklyn Urologic Research Group: Leadership Position; Allied Urological Services and Metropolitan Lithotripsy Associates: Leadership Position, Investment Interest, Employee; CHD Biosciences: Consultant or Advisor

Blake D. Hamilton, MD
Disclosures: MextMed, Inc.: Consultant or Advisor; Karl Storz Endoscopy: Meeting Participant or Lecturer; Cook Urological: Consultant or Advisor

Peter M. Knapp Jr., MD 
Disclosures: Medtronic: Scientific Study or Trial, Other; Strand Diagnostics LLC: Consultant or Advisor, Owner, Product Development

Surena F. Matin, MD
Disclosures: Mike Hogg Fund: Scientific Study or Trial; AT&T: Scientific Study or Trial

Arturo Mendoza-Valdes, MD
Disclosures: Bristol Myers: Scientific Study or Trial; AMGEN: Consultant or Advisor, Meeting Participant or Levturer; TEVA: Consultant or Advisor, Meeting Participant or Levturer; BAYER: Consultant or Advisor, Meeting Participant or Levturer;

David Fredrick Penson, MD
Disclosures: Patient-Centered Outcomes Research Institute: Scientific Study or Trial; Astellas: Scientific Study or Trial; medivation: Scientific Study or Trial; National Institutes of Health: Consultant or Advisor; US Agency for Healthcare Research and Quality: Consultant or Advisor, Scientific Study or Trial

Christopher Porter, MD
Disclosures: Nothing to disclose

Daniel Rukstalis, MD
Disclosures: Nothing to disclose

Sheila Stark, PhD
Disclosures: Nothing to disclose

Stephanie Stinchcomb, CPC
Disclosures: Accurate Coding Solutions: Consultant or Advisor; Board of Medical Specialty Coding: Consultant or Advisor

Martha K. Terris, MD
Disclosures: Nothing to disclose

J. Brantley Thrasher, MD
Disclosures: Oakstone Publishing's Practical Reviews in Urology: Leadership Position; Urology Times: Leadership Position; Residency Review Committee in Urology: Leadership Position; Society of Urologic Oncology: Leadership Position; SUCPD: Leadership Position

Edouard J. Trabulsi, MD
Disclosures: Centocor: Consultant or Advisor, Meeting Participant or Lecturer; Dendronl: Consultant or Advisor, Meeting Participant or Lecturer; Medivation: Consultant or Advisor, Meeting Participant or Lecturer; Photocure: Consultant or Advisor

Method Of Participation: 

Learners will participate in this online educational activity by taking the pretest, viewing the online video and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 1.0 hours

Renewal Date: September, 2017
Expiration Date: September, 2020

Original Release Date: November, 2014

Accreditation: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: 

The American Urological Association designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to
provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: 

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence‐based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Conflict of Interest Review Work Group or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point‐counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off‐label or Unapproved Use of Drugs or Devices:

 The audience is advised that this continuing medical education activity may contain reference(s) to off‐label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation

Accreditation Period

Course opens: 
09/01/2017
Course expires: 
09/01/2020
Please login or register to take this course.